Funding for this research was provided by:
JSPS KAKENHI (16K08221, 19K07492)
Japan Rheumatism Foundation (H27)
Suhara Memorial Foundation (H25)
FUGAKU TRUST for medical research (H26)
Academic supports of Pfizer (H28-31)
Academic supports of Chugai (H29)
Academic supports of Astellas (H29-31)
Academic supports of Eli Lilly (H30)
Article History
Received: 1 October 2019
Accepted: 13 February 2020
First Online: 16 February 2020
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest.